Active Funding Opportunities and Notices for NICHD
NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.
NOTs and Active NOFOs for NICHD
Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.
| Number Sort ascending | Exp. Date | Activity Code(s) | Title |
|---|---|---|---|
| PAR-22-236 | November 17, 2024 | R21 | Advancing Methods for Safe, Noninvasive, Real Time Assessment of Placenta Development and Function Across Pregnancy (R21 Clinical Trial Not Allowed) |
| PAR-22-233 | March 2, 2025 | R61/R33 | Time-Sensitive Opportunities for Health Research (R61/R33 Clinical Trial Not Allowed) |
| PAR-22-224 | May 26, 2025 | R25 | NICHD Research Education Programs (R25 Clinical Trial Not Allowed) |
| PAR-22-222 | December 8, 2024 | R01 | Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional) |
| PAR-22-215 | September 8, 2025 | R01 | Advancing Research to Understand Congenital Malformations (R01 Clinical Trial Not Allowed) |
| PAR-22-195 | September 8, 2025 | R25 | INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Research Short Course (R25 Independent Clinical Trial Not Allowed) |
| PAR-22-167 | October 18, 2024 | UG3/UH3 | Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional) |
| PAR-22-118 | June 7, 2024 | R25 | International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed) |
| PAR-22-116 | June 7, 2024 | D43 | International Bioethics Research Training Program (D43 Clinical Trial Optional) |
| PAR-22-109 | May 8, 2025 | R21 | Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) |
| PAR-22-106 | September 8, 2025 | R03 | Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) |
| PAR-22-105 | May 8, 2025 | R01 | Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) |
| PAR-22-101 | October 18, 2024 | R21 | Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed) |
| PAR-22-100 | October 18, 2024 | R03 | Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed) |
| PAR-22-098 | December 10, 2024 | R21 | Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional) |
| PAR-22-097 | December 10, 2024 | R01 | Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional) |
| PAR-22-060 | January 8, 2025 | R15 | Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) |
| PAR-21-357 | January 8, 2025 | R15 | Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required) |
| PAR-21-355 | November 17, 2024 | R21 | Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional) |
| PAR-21-354 | November 17, 2024 | R03 | Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R03 - Clinical Trial Optional) |
BACK TO TOP